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Abstract— Diabetes Mellitus (DM) is a chronic metabolic disorder disease, caused by the insufficiency and ineffectiveness of insulin 
utilizing and then result in insulin resistance. This study purposed to identify the effect of purple tofu intervention, which made from 
black soybean in improving hyperglycemic conditions and nutritional intake of type 2 diabetes mellitus (T2DM). An intervention of 
purple soy tofu was performed for 28 days with 20 subjects, divided into two groups (control and treated group), and selected 
purposively. Eighty-five grams of tofu was served with additional vegetable broth in the intervention group, while people in the 
control group did not accept any treatment. There was a significant improvement in hyperglycemia and nutritional intake of diabetics 
(p <0.05) at the end of the intervention. Analysis of fasting blood glucose levels of respondents to purple tofu decreased from 
224.7±92.45 to 170.2±68.15; plasma insulin levels increased from 0.29±0.08 to 0.39±0.11. Our findings suggested that purple tofu 
interventions improved the condition of hyperglycemia in T2DM respondents through the elevating of plasma insulin levels. 
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I. INTRODUCTION 
Diabetes mellitus includes as a chronical disease, 
characterized by an exceeding threshold of glucose condition 
(hyperglycemia) [1]. The hyperglycemia tends to lead the 
synthesis of Reactithe ve Oxygen Species (ROS) that causes 
stress oxidative [2]. Excessive stress oxidative triggers an 
immune reaction such as inflammation [3]. ROS or free 
radicals attack the DNA of the pancreatic cell and causes β-
cell dysfunction, decreases the number of β-cells, and 
exacerbates the insulin resistance [4]. 
The prevalence of diabetics in 2015 reached 415 million 
people and was estimated to increase to 642 million people 
in 2040. Indonesia was the seventh ranking of diabetes 
mellitus in the world in 2015, with 10 million people of 
diabetics [5]. Diabetes mellitus may not be overcome, but it 
may be controlled by reducing the risk factors. Improving 
the dietary pattern and increasing physical activities are 
ways to decline obesity rates. Light exercise for 30 minutes, 
4-5 times a week repairs signaling of insulin [6]. The healthy 
diet is performed by consuming plant-based foods, which 
contain a high nutritional value, fiber, bioactive components, 
and low glycemic index (GI) [7].  
Tofu is well known as a soybean processed product in 
Indonesia. Tofu has high digestibility around 95%, and 
suitable to be consumed for all ages [8]. In addition, tofu is a 
satisfying food and is chosen as substitute food to regulate 
body weight or to reduce obesity [9]. Tofu contains high 
protein and essential amino acids, low saturated fat, high 
unsaturated fatty acids, cholesterol-free, a source of B 
vitamins, minerals, is flavones, phenolic components, and 
thiol (SH) [10], [11]. Commonly, tofu is made from yellow 
soybean, but purple tofu, which made from black soybean 
variety is rarely produced. Exploration of black soybean 
processed product such as tofu will raise the spirit of farmers 
to optimize the production of such variety. 
Purple tofu is a potential of food to repair diabetic 
metabolic syndrome conditions. Black soybeans contain 
bioactive components of isoflavones such as genistein (0.65 
mg/g), daidzein (3.67 mg/g), and anthocyanins (222.49 mg/g) 
[12]. Meanwhile, purple soy tofu contains daidzein 
isoflavones (19.72 mg/100 g), and genistein (18.32 mg/100 g) 
[13]. The number of bioactive components in black soybeans 
is higher than yellow soybeans. Scientific data which 
concern about the advantages of purple tofu consumption for 
the diabetic patient have not been available. Therefore, the 
purpose of the present study was to determine the effect of 
purple to consumption which is produced from black 
2065
soybean in improving hyperglycemic conditions and to 
increase the nutritional intake of  T2DM patients. 
II. MATERIAL AND METHOD 
A. Design, Place, and Time of Study 
 
The study was an experimental research design (Quasi-
Experimental Study), conducted from October 2014 to 
December 2015 at dr. Katie's clinic Dramaga Bogor, at 
Biochemical Laboratory, Department of Food Science and 
Technology, and Animal Disease Laboratory, Faculty of 
Veterinary Medicine, Bogor Agricultural Institute.  
B. Materials and Tools 
 
Purple tofu (Cikuray black soybean varieties, from a local 
plantation in Lampung), blood samples of respondents 
(before and after intervention), mouse monoclonal insulin 
antibody (Abcam, UK), mouse IgG antibody, HRP (Genetex, 
USA), TMB/3,3', 5,5'-tetramethylbenzidine liquid substrate 
(Sigma Aldrich, USA). The equipment used for blood 
analysis were centrifuge, ELISA reader, micropipette, 
microplate 96 well, and glucometer (Accu-check 
performance, USA). 
C. Steps of Study 
 
The study consisted of several steps. First was the 
respondent selection and ethical clearance submission. The 
respondents used met the inclusion (T2DM, 50-65 years of 
ages, blood glucose levels >200 mg/dL, and received 
recommendations from the physicians) and exclusion 
(pregnancy, gangrene, and smoking). The estimation of the 
number of respondents was determined by different test 
formula [14]. Ten respondents were fixed to each number of 
groups (intervention and control) and added with 10% 
dropout possibility. Respondents study were local citizens of 
Dramaga District, Bogor District. Ethical clearance was 
approved by The Ethical Commission of Institute of 
Research and Community Service of the Catholic University 
of Atmajaya Jakarta with number 576/III/LPPM-
PM.10.05/07/2014. The second step was to prepared purple 
tofu [15]; seeds were sorted, washed, soaked for 12 hours 
with the ratio (water 3: seeds 1), and drained from water 
residue. Seeds were ground with water at 80º-85ºC (8:1).  
Black soybeans porridge was boiled at 105ºC for ten minutes, 
filtered with 100 mesh, and soybean milk resulted. Milk was 
coagulated with CaSO4 at 70º-85ºC, mixed slowly until it 
separated from the way. Curds were pressed for 15-20 min 
to create a compact of tofu texture. The tofu was cut and 
soaked in cold water at 5ºC, boiled, and ready to serve. The 
third, the intervention of the subject. The intervention was 
performed for 28 days. Eighty-five grams of tofu was served 
with additional vegetable broth. Our team supervised the 
respondents to consume purple tofu for three days 
continuously, to ensure that tofu was eaten appropriately. 
Evaluation of purple tofu acceptance and impact of the 
intervention, on respondent health were performed by 
discussion and visual observation every seven days for four 
weeks. Analysis of Proximate [16] analyzed the purple tofu. 
Analysis of daily consumption pattern (food recall 24 hours 
method by using NutriSurvey Method) was obtained by 
interviewing of respondent every week. Data were analyzed 
by using bivariate analysis, to observe the difference of 
macro nutritional intake means between before and after the 
intervention. Fourth, blood collection. Blood was taken 
twice during the study, on day-0 when socialization of 
activity (before the intervention), and on day-28 after the 
intervention. Syringe took eight milliliters of blood and 
transferred into vacutainer, which contained EDTA as anti-
coagulant. Blood analysis consisted of fasting blood glucose 
[17] and insulin plasma levels. Fasting blood glucose was 
performed before and after tofu intervention. Respondents 
had to do fasting for 8 hours before the blood sample taken 
[18]. Blood was obtained from the fingertips and affixed to 
the glucometer strip. Measurements were performed in the 
morning between 7 am, and 9 am. A total of 100 μL plasma 
was diluted with carbonate/bicarbonate buffer and 
transferred into microplate 96 wells, incubated at 4°C for 24 
hours. The supernatant was discarded and washed with 250 
μL/well PBST solution for three times, 100 μL/well skim 
milk 5% was added and incubated at 37°C for an hour, 
discarded supernatant and washed with PBST three times. 
Mouse monoclonal insulin antibody was added as much as 
100 μL/well, incubated at 37oC for an hour. The supernatant 
was discarded and washed with PBST three times. Anti-
mouse anti-mouse polyclonal antibodies were added 100 
μL/well, incubated at 37°C for an hour. The supernatant was 
discarded and washed with PBST three times. The TMB 
substrate was added with 50 μL/well in the dark condition 
and incubated at 37°C for 15 min. Furthermore, 50 μL/well 
H2SO4 1N was added as stop solution. The color intensity 
was read using a micro plate reader at 450 nm wavelength 
[19].  
D. Data Analysis 
 
Data were analyzed by SPSS ver.22 using Mann Whitney 
test with 95% confidence interval to investigate the 
difference between fasting blood glucose level and plasma 
insulin level on control respondent and purple tofu 
intervention before and after intervention.  
III. RESULTS AND DISCUSSION 
 
A. Chemical Composition of Tofu Purple 
 
Evaluation of purple tofu nutrients included proximate 
analysis. Table 1 showed the chemical composition of purple 
tofu consists of water content, protein, fat, dietary fiber, ash, 
and Calcium. Purple tofu has high protein content in 
sufficient amount for diabetic’s respondent. Protein in 
soybean improves the lipid profile in hyperglycemic 
conditions of people with T2DM [20]. Furthermore, high 
dietary fiber in purple tofu plays a role as a sufficient food as 
a fiber source which is needed by diabetic patients. 
TABLE I 
THE CHEMICAL COMPOSITION OF PURPLE SOY TOFU 
Parameter Amount (db) 
Water content 5.24 
Protein 53.92 
Fat 26.33 
Soluble dietary fiber 4.33 
Ash 4.66 
Ca 0.78 
P 0.71 
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Dietary fiber repairs blood glucose levels, by delaying 
postprandial glucose absorption and gastric emptying time 
[21]. The limited content of carbohydrates and higher 
content of protein makes soy a good candidate for the 
management of glycemic response in diabetes and insulin 
resistance patients and more in general in metabolic diseases 
[22]. Soybean consumption improves blood lipid levels, 
regulates insulin under normal circumstances, and promotes 
weight loss [23]. Several physiological effects and clinical 
benefits of soy fiber are by lowering cholesterol level in 
patients with hypercholesterolemia, improving glucose 
tolerance, increasing insulin tolerance on hyperlipidemia and 
diabetic patients, and increasing stool volume to accelerate 
food transit times [24]. 
The purple tofu also contains high dietary fiber (Table 5), 
wherein the consumption of dietary fiber is needed for 
diabetics. Dietary fiber can improve blood glucose levels, as 
it slows postprandial glucose absorption and gastric 
emptying time [21]. Soy is a high-fiber diet that is ideal for 
diabetic patients diet [25]. Eating soy may improve blood 
lipid levels and regulate insulin under normal circumstances 
[26]. 
The physiological effects and clinical benefits of soy fiber 
are by lowering cholesterol in patients with 
hypercholesterolemia, improving glucose tolerance and 
insulin response in hyperlipidemia and diabetic patients, and 
increasing the volume of the stools to speed up food transit 
times [27], [28].  
 
B. Characteristics of Respondents  
 
Respondents involved in this research were people who 
live in one village near the campus of Bogor Agricultural 
Institute Dramaga. The rationale for the selection of 
respondents was that of having adjacent residence, activity, 
the economic level was almost the same, so it was expected 
that the respondents have eating habits and nutritional 
conditions were not much different. 
Two groups of respondents; purple soy tofu intervention 
and control group, the intervention group consisted of two 
males and eight females, whereas the control group 
consisted of three males and seven females. Based on body 
mass index (BMI) category, the number of normal 
respondents in the intervention group was five respondents, 
pre-obese were two respondents, and three others were obese. 
In the control group, normal BMI were two respondents, 
four respondents were pre-obese, and two respondents were 
obese. BMI category determination was based on less (≤18.5 
kg/m2), normal (18.5-24.9 kg/m2), pre-obesity (≥25 kg/m2), 
and obesity (≥30 kg/m2) [29]. Most of the respondents in 
this study were women in both groups, with overweight and 
pre-obese. The result of the study showed the prevalence of 
women with diabetes mellitus was higher than men because 
women’s activities were less than men. Therefore, blood 
glucose is less used to generate energy. Also, overweight 
(obese) respondents risk twice in developing diabetes 
mellitus than normal weight respondents [30]. 
 
 
 
 
 
TABLE II 
DATA ON ANTHROPOMETRIC AND BODY MASS INDEX (BMI) OF 
INTERVENTION GROUP 
Respondents Weight (Kg) 
Height 
(cm) BMI 
BMI 
Category 
Male     
1 55 159.5 21,62 Normal 
2 72.5 160.7 28.07 Pre Obese 
Female     
3 64.5 160.7 31.32 Obese  
4 68.5 154.5 28.70 Pre Obese  
5 51 146.0 23.93 Normal 
6 48.5 143.1 23.68 Normal 
7 45.5 152.1 19.67 Normal 
8 54.5 160.8 21.08 Normal 
9 84 158.0 33.65 Obese 
10 51.5 153.0 22.00 Normal 
*BMI was in accordance based on WHO (2006)0: Less (<18,5 kg/m2), 
normal (18,5-24.9 kg/m2), Pre Obese (>25 kg/m2),  Obese (>30 kg/m2) 
 
C. Nutritional Intake of Respondents 
 
The result of the nutritional intake of respondents with 
type 2 diabetes mellitus in the intervention and control group 
(by ignoring the consumption of purple tofu) was presented 
in Table 2. By consuming 85 g/day of purple tofu 
contributed protein, fat, and fiber (6.66g/day; 2.14 g/day; 
4.72 g/day, respectively) and calories (83.47 Kcal/day) in 
intervention group, or equivalent with 17% protein, 6.13% 
fat, and 58.70% fiber, and 6.62% energy. A detail 
calculation of nutritional intake contributing by purple tofu 
was showed in Table 3. 
 
TABLE III 
 THE COMPARISON OF DAILY NUTRITIONAL INTAKE BETWEEN 
INTERVENTION AND CONTROL GROUP 
Macronutrients Intervention group Control group 
Protein intake (g/day) 
Day-1 38.57±17.06 38.39±15.00 
Day-7 39.42±6.18 39.61±9.97 
Day-14 36.04±14.60 41.77±8.55 
Day-21 50.41±26.94 43.62±6.75 
Day-28 34.55±9.69 37.39±6.79 
Average 39.79±6.52 40.15±2.53 
From purple tofu 6.66 
Total of protein  intake  46.45 40.15 
Fat intake (g/day) 
Day ke-1 40.92±24.30 31.89±23.39 
Day ke-7 38.34±13.83 53.12±19.35 
Day ke-14 39.62±26.94 53.82±28.62 
Day ke-21 30.09±18.34 59.05±28.26 
Day ke-28 25.68±13.13 51.96±18.26 
Average 34.93±6.68 49.96±10.46 
From purple tofu 2.14 - 
Total of fat  intake 37.07 49.96 
Carbohydrate intake (g/day) 
Day-1 222.6±112.40 171.57±93.53 
Day-7 244.36±116.34 209.88±139.44 
Day-14 181.75±88.86 208.24±97.30 
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Day-21 166.46±119.04 212.82±81.27 
Day-28 191.29±120.59 226.24±47.77 
Average 201.292±31.63 205.75±20.37 
From purple tofu - -  
Total of carbohydrate  
intake 201.29 205.75 
Fibers intake (g/day) 
Day-1 9.38±4.20 6.05±4.09 
Day-7 9.17±5.25 8.4±4.42 
Day-14 7.6±4.71 9.7±5.80 
Day-21 7.13±3.51 11.42±5.50 
Day-28 7.01±3.01 12.84±6.19 
Average 8.05±1.13 9.68±2.63 
From purple tofu 4.72 - 
Total of fibers 12.77 9.68 
Energy (Kcal/day)   
Day-1 1372.85±536.84 1140.03±517.26 
Day-7 1464±417.31 2739.12±651.38 
Day-14 1214.95±299.89 1525.05±568.38 
Day-21 1120.47±546.81 1628.67±539.75 
Day-28 1127.3±533.81 1565.92±302.01 
Average 1259.57±153.09 1719.4±601.09 
From purple tofu 83.47 - 
Total of energy 1343.04 1719.4 
 
The daily nutritional intake of protein and fiber between 
intervention and control groups was almost same, but the 
number of protein and fiber intake in the intervention group 
was higher than the control group after purple tofu 
administration. Table 8 explained that the daily intake of 
protein and fiber was 46.45 g/day and 12.27 g/day. Fats and 
carbohydrates were 37.07 g/day and 201.29 g/day in the 
intervention group. Fat and carbohydrate intakes were 49.96 
g/day and 205.75 g/day, respectively in the control group. 
Dietary recommendation for people with diabetes is 
healthy foods with high fiber and low glycemic index (GI) 
and avoiding of fried foods [31]. Protein and fiber are the 
important components for DM patients, foods with high 
protein such as purple tofu can suppress the hunger [32]. 
Also, the fiber is significant for the body and is needed for 
DM patients, acts to slow the process of gastric emptying 
and the absorption of blood glucose by small intestine [33]. 
The requirement of fiber intake for adults is about 15% per 
day obtained from food. 
The higher amount of protein in the intervention group 
was due to the high intake of protein by adding purple tofu 
in diet regularly every day for 28 days. The purple tofu 
contains 6.66% protein of 85 g in a dish during the 
intervention. Meanwhile, the lower protein intake was 
showed in the control group, the absence of purple tofu 
contributed to elevating the protein intake. The amount of fat 
consumed for 28 days in the control group was higher than 
the intervention group. The different treatments between two 
different groups affected the intake of fat significantly. Low 
fat intake is expected to improve the condition of 
dyslipidemia as one of the triggers to worsen diabetes. 
The lower carbohydrate intake in the intervention group 
than in the control group indicated that respondents in 
intervention group began to understand how to manage 
diabetes mellitus by improving the quality of diet, by 
reducing the carbohydrate intake such as rice, bread and 
others with high GI content. Eating foods with a high 
number of GI leads to increase blood glucose level rapidly 
[34]. Blood glucose control plays a role in people with 
diabetes mellitus regarding GI content of food [35]. Besides, 
the lower intake of carbohydrates in the intervention group 
was affected by the level of satiety of tofu routinely 
consumed in the intervention group.  
D. Fasting Blood Glucose 
 
Fasting blood glucose is an early indicator of diabetes 
mellitus detection. Cut off of normal fasting blood glucose 
levels is 110 mg/dL [36]. Purple soy tofu is an alternative 
food for people with diabetes mellitus. Fig. 2 demonstrated 
that routinely consuming purple soy tofu in 28 days 
significantly decreased fasting blood glucose levels of the 
intervention group (P<0.05). 
 
Fig. 1  Fasting blood glucose level of T2DM 
 
Decreasing of fasting blood glucose levels also occurred 
in the control group, but statistically insignificant (P>0.05). 
The change in control and intervention group on 28 days did 
not show a significant decrease (P>0.05). Tofu is a highly 
nutritious food with high fibers, with low glycemic index 
and high digestibility rate and quite fulfilling. Tofu 
suppresses and controls the elevation of blood glucose levels, 
and indirectly improves insulin sensitivity in the diabetic 
patient. Also, bioactive components in tofu (anthocyanin and 
is flavones) play a role in regulating homeostasis of blood 
glucose and insulin in the blood [37]. 
E. Plasma Insulin Levels 
 
Insulin is a hormone secreted by β pancreatic cells, to 
control blood glucose levels in normal condition, by 
facilitating glucose uptake and regulating carbohydrate, fat, 
and protein metabolism. Insulin levels increase when blood 
glucose elevation occurs in plasma [38]. The quantity of 
available insulin on a T2DM patient is not proportional to 
blood glucose quantity [39]. Fig. 1 showed a significant 
increase in insulin levels (P <0.05) in the intervention group. 
Insulin levels tended to increase in the control group, but it 
was not statistically significant (P>0.05). The changes of 
insulin level in the intervention group after 28 days showed a 
significant difference (P<0.05) than in control group. 
Fig. 2 presented the condition of insulin deficiency in two 
groups. Increased insulin in the intervention group showed 
that the consumption of purple tofu leads higher insulin 
secretion of T2DM patients. High isoflavones content in 
purple tofu plays a role in increasing insulin secretion. In 
previous studies [40] indicated isoflavones in Tempe 
increased insulin secretion. Insulin level was also elevated in 
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the control group, although it was not statistically significant 
(P> 0.05). The increase was the result of socialization and 
education regarding the management of diabetes mellitus to 
patients, by applying a healthy diet and increase physical 
activities. 
 
Fig. 2  Plasma insulin level of T2DM 
F. Amino Acid Contents 
 
 
TABLE IV 
AMINO ACIDS  COMPONENTS IN PURPLE TOFU AND BLACK SOYBEANS 
BASED ON WHO 
 
Type of amino 
acid 
Amino acid (mg/g) 
Gross weight (gw) Dry weight (DW) 
Aspartic 1.86±0.21 6.16±0.04 
Glutamate 2.20±1.35 8.3±3.11 
Serine 0.81±0.01 2.66±0.07 
Histidine 0.36±0.01 1.24±0.01 
Gysin 0.65±0.01 2.16±0.07 
Tryptophan - - 
Threonine 0.56±0.01 1.84±0.03 
Arginine 1.21±0.15 3.53±0.19 
Alanin 0.83±0.91 2.77±0.02 
Tyrosine 0.62±0.01 2.05±0.01 
Methionine 0.19±0.02 0.69±0.01 
Valine 0.87±0.01 2.9±0.01 
Phenylalanine 1.00±0.01 3.35±0.01 
Isoleusin 0.85±0.01 2.84±0.04 
Leusin 1.35±0.01 4.53±0.01 
Lysine 0.99±0.09 2.93±0.84 
SAA - - 
AAA - - 
 
Amino acids are proteins, and there are two types of non-
essential amino acids that can be produced by the body, such 
as alanine, serine, glycine, glutamate, serine, and aspartate. 
While essential amino acids are amino acids that cannot be 
made by the body, obtained from food intakes, such as 
histidine, cysteine, methionine, isoleucine, lysine, leucine, 
methionine, phenylalanine, threonine, tryptophan, and valine. 
Consumption of purple tofu contributes to the availability of 
essential amino acids that are very important for the body. 
The purple tofu contained 15 amino acids (Table 4) 
consisting of eight essential amino acids. Glutamate was the 
highest number of amino acids compared to other amino 
acids. Glutamate is an amino acid that plays an important 
role in forming food flavors in tofu [12]. Also, arginine, 
serine, and lysine play an important role for the body by 
preventing inflammation by increasing the synthesis of GSH 
so that GSH content in cell elevates, followed by a decrease 
in inflammatory factors such as IL-1, IL-6, and TNF-α. 
Increased glutathione also enhances IL-2, so that T cells are 
activated to improve cellular and humoral immunity [18]. 
Purple tofu also contains bioactive components such as 
flavonoids that also act as antioxidants such as isoflavone 
and anthocyanin (Table 7). 
 
TABLE V 
BIOACTIVE COMPONENTS IN PURPLE TOFU  
 
Type of bioactive components Amount (mg/100g) 
Total flavonoid 42.02* 
Isoflavon :  
    Daidzein 19.72** 
    Genistein 18.32** 
Total anthocyanine 1.80*** 
Note: * = Meriyanti (2015); ** = Zuhri (2015); *** = Zakaria et al. (2016) 
 
Table 5 showed that purple tofu contained a total of 42.02 
mg / 100 g of flavonoid, Daidzen was 19.72 mg/100 g, and 
genistein was 18.32 mg / 100 g. Also, there was 1.80 mg/100 
g of anthocyanin in purple tofu [41, 13, 15]. The processing 
of soybeans into tofu reduces the number of active 
components such as isoflavones and anthocyanins. 
Consumption of normal daily intake of active components 
such as isoflavones to improve health according to FSC [42] 
is as much as 30 mg. 
IV. CONCLUSION 
Purple tofu which is made from black soybeans is a 
potential food to improve hyperglycemia conditions. It can 
be determined by the decrease of fasting blood glucose 
levels and elevation of plasma insulin levels. Moreover, soy 
tofu consumption for 28 days showed an increase in 
nutritional intake such as protein and fibers in T2DM 
patients. We recommended purple tofu as an alternative food 
on the diabetic diet. 
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